Sodium Methanesulfinate CAS 20277-69-4 Kemurnian >96,0% Pabrik Kemurnian Tinggi
Shanghai Ruifu Chemical Co., Ltd. minangka produsen terkemuka Sodium Methanesulfinate (CAS: 20277-69-4) kanthi kualitas dhuwur.Ruifu Chemical bisa nyedhiyakake pangiriman ing saindenging jagad, rega sing kompetitif, layanan sing apik, jumlah cilik lan akeh sing kasedhiya.Tuku Sodium Methanesulfinate,Please contact: alvin@ruifuchem.com
Jeneng Kimia | Sodium Methanesulfinate |
sinonim | Garam Natrium Asam Methanesulfinic |
Nomer CAS | 20277-69-4 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | CH5NaO2S |
Bobot Molekul | 104.1 |
Titik lebur | 222.0~226.0 ℃ (des.) (lit.) |
Kelarutan banyu | Larut ing banyu |
Sensitif | Sensitif Udara & Higroskopis |
COA & MSDS | kasedhiya |
asale | Shanghai, China |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Kristal Putih utawa Putih |
Kemurnian | >96.0% |
Rugi ing pangatusan | <1.00% |
Spektrum Infra Merah | Conforms kanggo Struktur |
Proton NMR Spectrum | Conforms kanggo Struktur |
Standar Tes | Standar Perusahaan |
Panggunaan | Penengah Farmasi;Sintesis Organik |
Simbol Bahaya | Xn - Mbebayani |
Kode Resiko | R22 - Mbebayani yen ditelan |
R20/21/22 - Mbebayani kanthi inhalasi, kena kulit lan yen ditelan. | |
Katrangan safety | S36/37 - Nganggo sandhangan pelindung lan sarung tangan sing cocog. |
S24/25 - Aja kontak karo kulit lan mripat. | |
ID UN | 2811 |
WGK Jerman | 3 |
Kelompok Packing | III |
Shanghai Ruifu Chemical Co., Ltd. pasokan komersial Sodium Methanesulfinate (CAS: 20277-69-4).Iku penengah pharmaceutical penting, kang bisa digunakake ing prodcution saka API (CAS 231277-92-2) lan (CAS 388082-78-8) API utawa intermediet liyane.(CAS 388082-78-8), anggota anyar saka inhibitor RTK kelas 4-anilinoquinazoline (RTKIs), diluncurake minangka perawatan lisan kanggo kanker payudara.Nduweni afinitas ganda kanggo EGFR lan HER2 tyrosine kinase.Iki dituduhake ing kombinasi karo Capecitabine kanggo nambani pasien kanker payudara lanjut utawa metastatik sing tumor overexpress HER2 lan sing wis nampa terapi sadurunge kalebu anthracycline, taxane, lan trastuzumab.